Item | Location | Contact |
Modulated DSC with refrigerated cooling TA Instruments Q100 DSC |
Bowne 4th floor | Prof. Patrick Mather |
Thermogravimetric Analysis TA Instruments Q500 |
Bowne 4th floor | Prof. Patrick Mather |
Rheometer Anton Paar MCR501 |
Bowne 4th floor | Prof. Patrick Mather |
Quartz Crystal Microbalance SRS QCM200 |
Bowne 4th floor | Prof. Patrick Mather |
Polarizing Microscope with optical microrheometer, heating/cooling stage, shear cell, spectrographic birefringence apparatus, and Mito CCD attachments Olympus BX-51 |
Bowne 4th floor | Prof. Patrick Mather |
Electrospinning apparatus Custom Built |
Bowne 4th floor | Prof. Patrick Mather |
Incubator Shakers New Brunswick C24 |
Bowne 4th floor | Prof. Patrick Mather |
E-beam Evaporator (Ti, Au only) Thermionics VE-100 |
CST 3-036 | Prof. Yan-Yeung Luk |
Ellipsometer(discrete wavelength ellipsometer room) | CST 4-041 | Prof. Yan-Yeung Luk |
Water Purification System Millipore RiOs 5 and Milli-Q Biocel A-10 |
CST 4-041 | Prof. Yan-Yeung Luk |
Polarizing Microscope Olympus BX-51 |
CST 3-036 | Prof. Yan-Yeung Luk |
Potensiostat Pine Model AFCBP1 |
CST 3-036 | Prof. Yan-Yeung Luk |
Labconco purifier vertical clean bench Laminar hood |
CST 3-036 | Prof. Yan-Yeung Luk |
Cryogenic Storage System VWR CryoPro BR-1 |
CST 3-036 | Prof. Yan-Yeung Luk |
Inverted Microscope Motic AE-31 |
CST 3-036 | Prof. Yan-Yeung Luk |
Scanning Electron Microscope with X-ray Spectrophotometer Joel 5600 |
Bowne 4th floor | Prof. Patrick Mather |
Atomic Force Microscope with Electrochemical Attachment and Nanoindentation Capabilityg | Bowne 4th floor | Prof. Jeremy Gilbert |
Digital Instruments Nanoscope III | Bowne 4th floor | Prof. Patrick Mather |
Hydraulic testing apparatus with 8500-Plus panel control and computer-controlled custom data collection Instron 1350 |
Bowne 4th floor | Prof. Patrick Mather |
Fourier Transform Infrared Spectrometer with AutoImage FTIR Microscope Perkin-Elmer Spectrum One |
Bowne 4th floor | Prof. Jeremy Gilbert |
Differential scanning calorimeter Perkin-Elmer Pyris 1 |
Bowne 4th floor | Prof. Patrick Mather |
Inverted Fluorescence Microscope and Imaging System Zeiss Axiovert 40 CFL with Phase Contrast |
Bowne 4th floor | Prof. Patrick Mather |
Custom built indentation system for microindentation of soft, hydrated polymers and biological materials | Bowne 4th floor | Prof. Jeremy Gilbert |
Rotational Viscometer Brookfield DV-E |
Bowne 4th floor | Prof. Patrick Mather |
MicroCT Scanner Scanco 40 |
SUNY Upstate | Prof. Kenneth Mann |
Biaxial Servohydraulic Mechanical Test Frame MTS Bionix |
SUNY Upstate | Prof. Kenneth Mann |
Fatigue crack growth measurement equipment Fractomat/KrakGage |
SUNY Upstate | Prof. Kenneth Mann |
Surface Profilometer Mitutoyo 178-923 |
SUNY Upstate | Prof. Kenneth Mann |
Viscometer with small sample adaptor Brookfield |
SUNY Upstate | Prof. Kenneth Mann |
SUN and PC Workstations with FEA Modeling and Medical Imaging Software PATRAN, MARC, NASTRAN and MIMICS |
SUNY Upstate | Prof. Kenneth Mann |
Digital Image Correlation System (2-D) with Spot RT Camera RapidCorrelator |
SUNY Upstate | Prof. Kenneth Mann |
Florescence Microscope with Motorized Z-Drive and Deconvolution Software. ZEISS AXIO IMAGER MOT M1 |
445 Link Hall | Prof. Dacheng Ren |
DNA and Protein Electrophoresis Systems | 445 Link Hall | Prof. Dacheng Ren |
Western Blot System | 445 Link Hall | Prof. Dacheng Ren |
Spectrophotometer Gensys 5 |
445 Link Hall | Prof. Dacheng Ren |
Microplate reader FLx800, Bio-Tek Instruments, Inc. |
445 Link Hall | Prof. Dacheng Ren |
Microcentrifuge Machines 5415D & 5415R, Eppendorf |
445 Link Hall | Prof. Dacheng Ren |
Micropulser Electroporator FLx800, Bio-Tek Instruments, Inc. |
445 Link Hall | Prof. Dacheng Ren |
Luminometer 20/20n, Turner Design |
445 Link Hall | Prof. Dacheng Ren |
Biofilm Flow Chamber Systems | 445 Link Hall | Prof. Dacheng Ren |
SBI Rooms
David Marcus
David is currently a Managing Director of VIMAC Milestone Medica, LP, an early stage life science fund with VIMAC Ventures, LLC, a Boston based venture capital firm. The fund invests in the pharmaceutical, medical device and instrument sectors with start-up companies based on emerging technologies from leading academic institutions. At VIMAC, David participates in the formation and capitalization of companies, and working closely with the Fund’s portfolio companies, is involved in licensing transactions, collaborative research agreements and clinical trial activities.
Before joining VIMAC, David had over twenty-five years of business development and new venture experience including with Colgate-Palmolive in their corporate M&A group, as well as CFO of a Colgate subsidiary and Director of M&A, Industrial Products for Colgate’s billion dollar health care and industrial specialty subsidiary, The Kendall Company. At Kendall, David developed and implemented a strategic growth plan through acquisition, and later went on to start up and run an in-house industrial polymer membrane business, which he grew, spun off and successfully sold to a large multinational company. Most recently, before joining VIMAC, David was a General Partner with Wellfleet Investments in Boston, a private equity placement firm that developed a portfolio of emerging life science technologies from leading medical research institutions. While at Wellfleet, he also served as CEO of a medical clinic established by the firm based on an advanced gastrointestinal rehabilitation therapy developed at a Harvard teaching hospital.
David is a graduate of Syracuse University (’70, BA, Political Science) and is a member of the Board of Visitors for SU’s College of Arts and Sciences. He holds an MBA from Pace University. He lives in Newton, MA with his wife and two daughters.
Photo Gallery
Gallery
David Marcus
David is currently a Managing Director of VIMAC Milestone Medica, LP, an early stage life science fund with VIMAC Ventures, LLC, a Boston based venture capital firm. The fund invests in the pharmaceutical, medical device and instrument sectors with start-up companies based on emerging technologies from leading academic institutions. At VIMAC, David participates in the formation and capitalization of companies, and working closely with the Fund’s portfolio companies, is involved in licensing transactions, collaborative research agreements and clinical trial activities.
Before joining VIMAC, David had over twenty-five years of business development and new venture experience including with Colgate-Palmolive in their corporate M&A group, as well as CFO of a Colgate subsidiary and Director of M&A, Industrial Products for Colgate’s billion dollar health care and industrial specialty subsidiary, The Kendall Company. At Kendall, David developed and implemented a strategic growth plan through acquisition, and later went on to start up and run an in-house industrial polymer membrane business, which he grew, spun off and successfully sold to a large multinational company. Most recently, before joining VIMAC, David was a General Partner with Wellfleet Investments in Boston, a private equity placement firm that developed a portfolio of emerging life science technologies from leading medical research institutions. While at Wellfleet, he also served as CEO of a medical clinic established by the firm based on an advanced gastrointestinal rehabilitation therapy developed at a Harvard teaching hospital.
David is a graduate of Syracuse University (’70, BA, Political Science) and is a member of the Board of Visitors for SU’s College of Arts and Sciences. He holds an MBA from Pace University. He lives in Newton, MA with his wife and two daughters.